Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.

Gukasyan, Natalie; Davis, Alan K; Barrett, Frederick S; Cosimano, Mary P; Sepeda, Nathan D; Johnson, Matthew W; Griffiths, Roland R

Gukasyan, Natalie; Davis, Alan K; Barrett, Frederick S; Cosimano, Mary P; Sepeda, Nathan D; Johnson, Matthew W; Griffiths, Roland R.

Afiliação

Gukasyan N; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Davis AK; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Barrett FS; College of Social Work, The Ohio State University, Columbus, OH, USA.
Cosimano MP; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sepeda ND; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Johnson MW; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Griffiths RR; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

J Psychopharmacol ; 36(2): 151-158, 2022 02.

Article em En | MEDLINE | ID: mdl-35166158

Assuntos

Antidepressivos/farmacologia; Transtorno Depressivo Maior/terapia; Alucinógenos/farmacologia; Psilocibina/farmacologia; Adulto; Idoso; Antidepressivos/administração & dosagem; Antidepressivos/efeitos adversos; Terapia Combinada; Transtorno Depressivo Maior/fisiopatologia; Feminino; Seguimentos; Alucinógenos/administração & dosagem; Alucinógenos/efeitos adversos; Humanos; Masculino; Pessoa de Meia-Idade; Estudos Prospectivos; Psilocibina/administração & dosagem; Psilocibina/efeitos adversos; Escalas de Graduação Psiquiátrica; Psicoterapia/métodos; Fatores de Tempo; Resultado do Tratamento; Adulto Jovem

Palavras-chave

Insight; long-term effects; major depressive disorder; mystical experience; psilocybin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psilocibina / Transtorno Depressivo Maior / Alucinógenos / Antidepressivos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google